In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats

Physiology and Behavior

Volumn 80, Issue 1, 2003, Pages 109-114

  Ferguson, Sherry A ^a   Gough, Bobby J ^a   Cada, Amy M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Amphetamine; Dopamine; Microdialysis; Spontaneously hypertensive rat; Striatum; Wistar Kyoto

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DEXAMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DOSE RESPONSE; ESSENTIAL HYPERTENSION; IN VIVO STUDY; INJECTION; MALE; MEASUREMENT; METABOLITE; MICRODIALYSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SAMPLE; STIMULATION; STRAIN DIFFERENCE; TIME;

EID: 0141991280     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00214-2     Document Type: Article

References (44)

1. Boix F., Qiao S.-W., Kolpus T., Sagvolden T. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder. Behav. Brain Res. 94:1998;153-162.
2. Carey M.P., Diewald L.M., Esposito F.J., Pellicano M.P., Carnevale U.A.G., Sergeant J.A.et al. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav. Brain Res. 94:1998;173-185.
3. Ferguson SA, Cada AM. A longitudinal study of short- and long-term activity levels in male and female spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Behav Neurosci [in press].
4. Ferguson S.A., Flynn K.M., Delclos K.B., Newbold R.R., Gough B.J. Effects of lifelong dietary exposure to genistein or nonylphenol on amphetamine-stimulated striatal dopamine release in male and female rats. Neurotoxicol. Teratol. 24:2002;37-45.
5. Ferguson SA, Gray EP, Cada AM. Early behavioral development in the spontaneously hypertensive rat: a comparison with the Wistar-Kyoto and the Sprague-Dawley strains. Behav Neurosci [in press].
6. Ferguson S.A., Gray E.P., Cada A.M. Increased maze learning abilities in the spontaneously hypertensive rat (SHR). Soc. Neurosci. Abs. 27:2001;952.15.
7. Fuller R.W., Hemrick-Luecke S.K., Wong D.T., Pearson D., Threlkeld P.G., Hynes M.D. III Altered behavioral responses to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rat. J. Pharmacol. Exp. Ther. 227:1983;354-359.
8. Hellstrand K., Engel J. Locomotor activity and catecholamine receptor binding in adult normotensive and spontaneously hypertensive rats. J. Neural Transm. 48:1980;57-63.
9. Holson R.R., Bowyer J.F., Clausing P., Gough G. Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion. Brain Res. 739:1996;301-307.
10. Howes L.G., Rowe P.R., Summers R.J., Louis W.J. Age related changes of catecholamines and their metabolites in central nervous system regions of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Clin. Exp. Hypertens., Part A Theory Pract. 6:1984;2263-2277.
11. Hynes M.D., Langer D.H., Hymson D.L., Pearson D.V., Fuller R.W. Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats. Pharmacol. Biochem. Behav. 23:1985;445-448.
12. Inada T., Polk K., Jin C., Purser C., Hume A., Hoskins B.et al. Cocaine elevates striatal dopamine efflux in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res. Bull. 28:1992;227-231.
13. Johnson M.L., Ely D.L., Turner M.E. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension. 19:1992;425-427.
14. Kirouac G.J., Ganguly P.K. Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience. 52:1993;135-141.
15. Kuczenski R., Segal D.S., Cho A.K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15:1995;1308-1317.
16. Kurtz T.W., Montano M., Chan L., Kabra P. Molecular evidence of genetic heterogeneity in Wistar-Kyoto rats: implications for research with the spontaneously hypertensive rat. Hypertension. 13:1989;188-192.
17. Le Fur G., Guilloux F., Kabouche M., Mitrani N., Ferris O., Uzan A. Central dopaminergic neurons during development of genetic and DOCA-salt hypertension in the rat. Dev. Brain Res. 1:1981;153-163.
18. Lim D.K., Ito Y., Hoskins B., Rockhold R.W., Ho I.K. Comparative studies of muscarinic and dopamine receptors in three strains of rats. Eur. J. Pharmacol. 165:1989;279-287.
19. Linthorst A.C.E., de Jong W., De Boer T., Versteeg D.H.G. Dopamine D1 and D2 receptors in the caudate nucleus of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. Brain Res. 602:1993;119-125.
20. Linthorst A.C.E., De Lang H., de Jong W., Versteeg D.H.G. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur. J. Pharmacol. 201:1991;125-133.
21. 14C]acetylcholine release from nucleus caudatus slices: differences between spontaneously hypertensive rats and Wistar-Kyoto rats. Brain Res. 509:1990;266-272.
22. Linthorst A.C.E., van Giersbergen P.L.M., Gras M., Versteeg D.H.G., de Jong W. The nigrostriatal dopamine system: role in development of hypertension in spontaneously hypertensive rats. Brain Res. 639:1994;261-268.
23. Russell W., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. Bull. 53:2000;187-192.
24. Russell V., de Villiers A., Sagvolden T., Lamm M., Taljaard J. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res. 676:1995;343-351.
25. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav. Brain Res. 94:1998;163-171.
26. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24:2000;31-39.
27. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.-L., Spinnangr I., Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav. Neural Biol. 58:1992;103-112.
28. Sam P.M., Justice J.B. Jr. Effect of general microdialysis-induced depletion on extracellular dopamine. Anal. Chem. 68:1996;724-728.
29. Samani N.J., Swales J.D., Jeffreys A.J., Morton D.B., Naftilan A.J., Lindpaintner K.et al. DNA fingerprinting of spontaneously hypertensive and Wistar-Kyoto rats: implications for hypertension research. J. Hypertens. 7:1989;809-816.
30. Sohn H.-S., Park Y.-N., Lee S.-R. Effect of immobilization stress on brain polyamine levels in spontaneously hypertensive and Wistar-Kyoto rats. Brain Res. Bull. 57:2002;575-579.
31. St. Lezin E., Simonet L., Pravenec M., Kurtz T.W. Hypertensive strains and normotensive 'control' strains: how closely are they related? Hypertension. 19:1992;419-424.
32. Sutoo D., Akiyama K., Matsukura T., Nakamoto R.K. Decrease of central dopamine level in the adult spontaneously hypertensive rat related to the calcium metabolism disorder. Brain Res. Bull. 30:1993;107-113.
33. 3H]dopamine release by neuropeptide Y in rat striatal slices. Eur. J. Pharmacol. 321:1997;5-11.
34. Tsuda K., Tsuda S., Nishio I., Masuyama Y., Goldstein M. Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am. J. Hypertens. 11:1998;1475-1479.
35. Van den Buuse M., Lambert G., Fluttert M., Eikelis N. Cardiovascular and behavioural responses to psychological stress in spontaneously hypertensive rats: effects of treatment with DSP-4. Behav. Brain Res. 119:2001;131-142.
36. Van den Buuse M., Linthorst A.C.E., Versteeg D.H.G., De Jong W. Role of brain dopamine systems in the development of hypertension in the spontaneously hypertensive rat. Clin. Exp. Hypertens. A13:1991;653-659.
37. Van den Buuse M., De Jong W. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J. Pharmacol. Exp. Ther. 248:1989;1189-1196.
38. Van den Buuse M., Veldhuis H.D., Versteeg D.H.G., De Jong W. Behavioural factors contribute to the development of spontaneous hypertension in rats. J. Hypertens. 3(Suppl. 3):1985;S101-S103.
39. Van den Buuse M., Versteeg D.H.G., De Jong W. Brain dopamine depletion by lesions in substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat. Brain Res. 368:1986;69-78.
40. Versteeg D.H.G., Palkovits M., Van der Gugten J., Vijnen H.L.J.M., Smeets G.W.M., De Jong W. Catecholamine content of individual brain regions of spontaneously hypertensive rats (SH-rats). Brain Res. 112:1976;429-434.
41. Watanabe Y., Fujita M., Ito Y., Okada T., Kusuoka H., Nishimura T. Brain dopamine transporter in spontaneously hypertensive rats. J. Nucl. Med. 38:1997;470-474.
42. Watanabe M., Tsuruta S., Inoue Y., Kinuya M., Ogawa K., Mamiya T.et al. Dopamine D1 and D2 receptors in spontaneously hypertensive rat brain striatum. Can. J. Physiol. Pharm. 67:1989;1596-1597.
43. Yu Z.J., Jin C., Rockhold R.W., Hoskins B., Ho I.K. Site and mechanism of behavioral tolerance to cocaine: a study of dopamine release in Wistar-Kyoto and spontaneously hypertensive rats. Neurochem. Res. 18:1993;1203-1209.
44. Yu Z.J., Lim D.K., Hoskins B., Rockhold R.W., Ho I.K. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites. Neurochem. Res. 15:1990;613-619.